Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 12501-12550 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04228991
Hypofractionated LocoRegional Radiotherapy in Breast Cancer
PHASE3
Active, not recruiting
588 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2030
3 conditions
1 sponsor
20 locations
NCT05286242
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
N/A
Active, not recruiting
400 participants
Started: Feb 10, 2021 · Completed: Jun 30, 2026
3 conditions
3 sponsors
1 location
NCT04760275
Fluoxetine vs CBT in Childhood Anxiety Disorders
PHASE3
Active, not recruiting
316 participants
Started: Feb 10, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04349514
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)
N/A
Active, not recruiting
300 participants
Started: Feb 10, 2021 · Completed: Oct 31, 2025
1 condition
8 sponsors
7 locations
NCT07120269
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
NA
Active, not recruiting
500 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04850287
Improving Health Awareness Using Social Network Interventions
NA
Active, not recruiting
2,000,000 participants
Started: Feb 10, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04517851
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
PHASE2
Active, not recruiting
15 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04721132
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
PHASE2
Active, not recruiting
16 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2027
5 conditions
1 sponsor
2 locations
NCT04576442
Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)
NA
Active, not recruiting
452 participants
Started: Feb 9, 2021 · Completed: Sep 30, 2025
1 condition
4 sponsors
1 location
NCT04750915
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
N/A
Active, not recruiting
566,398 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2050
3 conditions
1 sponsor
1 location
NCT04500041
Casting Vs Bracing for Idiopathic Early-Onset Scoliosis
NA
Active, not recruiting
71 participants
Started: Feb 9, 2021 · Completed: Jan 30, 2026
2 conditions
3 sponsors
26 locations
NCT04594993
INFINITY™ With ADAPTIS™ Technology Study
N/A
Active, not recruiting
200 participants
Started: Feb 9, 2021 · Completed: Nov 30, 2035
1 condition
1 sponsor
13 locations
NCT04598230
Partners in Caring for Anxious Youth
PHASE3
Active, not recruiting
468 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2026
3 conditions
3 sponsors
3 locations
NCT04657081
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
PHASE1/PHASE2
Active, not recruiting
101 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
34 locations
NCT04805814
Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial
NA
Active, not recruiting
280 participants
Started: Feb 9, 2021 · Completed: Oct 1, 2034
6 conditions
4 sponsors
3 locations
NCT07167069
India HIV-CervCa Project
N/A
Active, not recruiting
180 participants
Started: Feb 9, 2021 · Completed: May 31, 2026
3 conditions
3 sponsors
1 location
NCT04696692
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
NA
Active, not recruiting
60 participants
Started: Feb 9, 2021 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04583774
Developing an EEG Paradigm to Study Prediction Error in Anorexia Nervosa
NA
Active, not recruiting
47 participants
Started: Feb 9, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04148417
Clinical Study of the Solo+ Tympanostomy Tube Device
NA
Active, not recruiting
27 participants
Started: Feb 9, 2021 · Completed: Sep 30, 2024
2 conditions
1 sponsor
2 locations
NCT05053568
Image Supported Lead Placement in CRT
NA
Active, not recruiting
130 participants
Started: Feb 8, 2021 · Completed: Oct 31, 2025
1 condition
4 sponsors
7 locations
NCT04714840
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
NA
Active, not recruiting
181 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04545151
Verapamil SR in Adults With Type 1 Diabetes
PHASE2
Active, not recruiting
138 participants
Started: Feb 8, 2021 · Completed: May 31, 2026
1 condition
2 sponsors
22 locations
NCT04134598
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
PHASE3
Active, not recruiting
926 participants
Started: Feb 8, 2021 · Completed: Mar 31, 2030
1 condition
2 sponsors
1 location
NCT04736173
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
PHASE2
Active, not recruiting
169 participants
Started: Feb 8, 2021 · Completed: May 31, 2027
4 conditions
2 sponsors
92 locations
NCT04776434
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
NA
Active, not recruiting
723 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2028
1 condition
1 sponsor
27 locations
NCT04229979
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
PHASE3
Active, not recruiting
127 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
73 locations
NCT04515524
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
N/A
Active, not recruiting
100 participants
Started: Feb 5, 2021 · Completed: Nov 5, 2026
1 condition
1 sponsor
30 locations
NCT04387734
Effects of Ocrevus in Relapsing Multiple Sclerosis
PHASE4
Active, not recruiting
60 participants
Started: Feb 5, 2021 · Completed: Sep 30, 2025
1 condition
2 sponsors
2 locations
NCT04739696
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.
NA
Active, not recruiting
510 participants
Started: Feb 5, 2021 · Completed: Sep 30, 2026
4 conditions
2 sponsors
1 location
NCT04103554
Sacubitril/Valsartan in Left Ventricular Assist Device Recipients
PHASE4
Active, not recruiting
60 participants
Started: Feb 5, 2021 · Completed: Feb 28, 2025
1 condition
1 sponsor
6 locations
NCT04567615
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
PHASE2
Active, not recruiting
266 participants
Started: Feb 4, 2021 · Completed: Oct 3, 2025
5 conditions
1 sponsor
65 locations
NCT04340258
Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Feb 4, 2021 · Completed: Sep 4, 2025
1 condition
2 sponsors
2 locations
NCT04341779
Simplifying Treatment and Monitoring for HIV (STREAM HIV)
NA
Active, not recruiting
539 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2025
2 conditions
3 sponsors
1 location
NCT04699123
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
159 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2025
1 condition
4 sponsors
1 location
NCT04742387
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
N/A
Active, not recruiting
40 participants
Started: Feb 4, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT04431726
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
PHASE3
Active, not recruiting
55 participants
Started: Feb 4, 2021 · Completed: May 18, 2030
1 condition
1 sponsor
31 locations
NCT04799119
Multi-site Animal Assisted Intervention for Children With DD and Their Family Dog
NA
Active, not recruiting
100 participants
Started: Feb 4, 2021 · Completed: Aug 29, 2025
2 conditions
1 sponsor
1 location
NCT04190550
Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
PHASE1
Active, not recruiting
24 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2026
2 conditions
1 sponsor
6 locations
NCT04503772
Preoperative Stereotactic Radiosurgery for Brain Metastases
PHASE2
Active, not recruiting
70 participants
Started: Feb 4, 2021 · Completed: Apr 30, 2026
1 condition
2 sponsors
8 locations
NCT04458402
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer
NA
Active, not recruiting
15 participants
Started: Feb 4, 2021 · Completed: Jul 4, 2026
1 condition
1 sponsor
1 location
NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
PHASE2
Active, not recruiting
45 participants
Started: Feb 4, 2021 · Completed: Sep 30, 2025
3 conditions
4 sponsors
1 location
NCT04746950
ALICIA (Acalabrutinib in CLL Therapy)
N/A
Active, not recruiting
90 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
12 locations
NCT04822688
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
N/A
Active, not recruiting
141 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04635397
Immunomonitoring After Hematopoietic Stem Cell Transplantation
N/A
Active, not recruiting
60 participants
Started: Feb 3, 2021 · Completed: Aug 18, 2026
1 condition
1 sponsor
1 location
NCT04624477
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
N/A
Active, not recruiting
450 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2034
3 conditions
10 sponsors
8 locations
NCT06324591
Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients
NA
Active, not recruiting
30 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
3 locations
NCT04701151
NORTH-REG Dwell-Time Study
PHASE4
Active, not recruiting
314 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2030
1 condition
12 sponsors
11 locations
NCT04875286
Patient Reported Symptom Control With THC or CBD Use
N/A
Active, not recruiting
200 participants
Started: Feb 3, 2021 · Completed: Feb 2, 2027
3 conditions
1 sponsor
2 locations
NCT04755283
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
PHASE2
Active, not recruiting
1,287 participants
Started: Feb 2, 2021 · Completed: Dec 29, 2028
2 conditions
3 sponsors
92 locations
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
PHASE1
Active, not recruiting
48 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2024
31 conditions
1 sponsor
7 locations
Previous
1
More pages
248
249
250
251
252
253
254
More pages
431
Next